Go to main content

FCDO ODA allocations for 2021/22 were announced on 21 April 2021. Changes to individual programmes are underway. The information on this website may not reflect the latest allocated budgets for this year. This information will be updated in due course.

  1. Home
  2. Nigeria

UK - Foreign, Commonwealth and Development Office (FCDO)


UK aid from the British people

Project Data Last Updated: 26/08/2021

IATI Identifier: GB-1-202979

Partner Projects

Abt Britain Limited

  • Support to the National Malaria Programme - Phase II in Nigeria (SuNMaP II) SuNMaP II will improve the planning, financing and delivery of sustainable and replicable pro-poor services for malaria in supported states by working with the Nigerian government, the Global Fund, DFID’s other programmes and other donors to: (i) Strengthen government stewardship, including planning and budgeting for malaria control, strengthening financial management and expenditure tracking as well as Nigerian government funding for malaria control; (ii) Strengthen procurement and supply systems to ensure the sustainable availability of malaria commodities; (iii) Support local health authorities to develop and scale up delivery systems for highly effective interventions such as Integrated Community Case Management; (iv) Support local health authorities and civil society to engage individuals and institutions to use malaria control measures and advocate for more domestic funding; and (v) Support local malaria control agencies to improve their use of research and evidence. Abt Associates provides technical assistance to expenditure tracking and domestic resource mobilisation activities. Total Project Budget: £1,453,830 FCDO Funding: £395,654

This site uses cookies

We use Google Analytics to measure how you use the website so we can improve it based on user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the internal pages you visit, how long you spend on each page and what you click on while you're visiting the site. Read more